|  Help  |  About  |  Contact Us

Publication : Enhanced IL-2 in early life limits the development of TFH and protective antiviral immunity.

First Author  Pyle CJ Year  2021
Journal  J Exp Med Volume  218
Issue  12 PubMed ID  34665220
Mgi Jnum  J:312858 Mgi Id  MGI:6794024
Doi  10.1084/jem.20201555 Citation  Pyle CJ, et al. (2021) Enhanced IL-2 in early life limits the development of TFH and protective antiviral immunity. J Exp Med 218(12)
abstractText  T follicular helper cell (TFH)-dependent antibody responses are critical for long-term immunity. Antibody responses are diminished in early life, limiting long-term protective immunity and allowing prolonged or recurrent infection, which may be important for viral lung infections that are highly prevalent in infancy. In a murine model using respiratory syncytial virus (RSV), we show that TFH and the high-affinity antibody production they promote are vital for preventing disease on RSV reinfection. Following a secondary RSV infection, TFH-deficient mice had significantly exacerbated disease characterized by delayed viral clearance, increased weight loss, and immunopathology. TFH generation in early life was compromised by heightened IL-2 and STAT5 signaling in differentiating naive T cells. Neutralization of IL-2 during early-life RSV infection resulted in a TFH-dependent increase in antibody-mediated immunity and was sufficient to limit disease severity upon reinfection. These data demonstrate the importance of TFH in protection against recurrent RSV infection and highlight a mechanism by which this is suppressed in early life.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

9 Bio Entities

0 Expression